These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells. Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments. Shen Y; Grisdale CJ; Islam SA; Bose P; Lever J; Zhao EY; Grinshtein N; Ma Y; Mungall AJ; Moore RA; Lun X; Senger DL; Robbins SM; Wang AY; MacIsaac JL; Kobor MS; Luchman HA; Weiss S; Chan JA; Blough MD; Kaplan DR; Cairncross JG; Marra MA; Jones SJM Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19098-19108. PubMed ID: 31471491 [TBL] [Abstract][Full Text] [Related]
10. CD44 expression in the tumor periphery predicts the responsiveness to bevacizumab in the treatment of recurrent glioblastoma. Nishikawa M; Inoue A; Ohnishi T; Yano H; Kanemura Y; Kohno S; Ohue S; Ozaki S; Matsumoto S; Suehiro S; Nakamura Y; Shigekawa S; Watanabe H; Kitazawa R; Tanaka J; Kunieda T Cancer Med; 2021 Mar; 10(6):2013-2025. PubMed ID: 33543833 [TBL] [Abstract][Full Text] [Related]
11. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306 [TBL] [Abstract][Full Text] [Related]
12. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway. Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149 [TBL] [Abstract][Full Text] [Related]
13. TPD52L2 impacts proliferation, invasiveness and apoptosis of glioblastoma cells via modulation of wnt/β-catenin/snail signaling. Qiang Z; Jun-Jie L; Hai W; Hong L; Bing-Xi L; Lei C; Wei X; Ya-Wei L; Huang A; Song-Tao Q; Yun-Tao L Carcinogenesis; 2018 Feb; 39(2):214-224. PubMed ID: 29106517 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic targeting of SLC30A3 by HDAC1 is related to the malignant phenotype of glioblastoma. Zhang L; Liu Z; Dong Y; Kong L IUBMB Life; 2021 May; 73(5):784-799. PubMed ID: 33715270 [TBL] [Abstract][Full Text] [Related]
15. Significance of perivascular tumour cells defined by CD109 expression in progression of glioma. Shiraki Y; Mii S; Enomoto A; Momota H; Han YP; Kato T; Ushida K; Kato A; Asai N; Murakumo Y; Aoki K; Suzuki H; Ohka F; Wakabayashi T; Todo T; Ogawa S; Natsume A; Takahashi M J Pathol; 2017 Dec; 243(4):468-480. PubMed ID: 28888050 [TBL] [Abstract][Full Text] [Related]
16. RCC2 promotes proliferation and radio-resistance in glioblastoma via activating transcription of DNMT1. Yu H; Zhang S; Ibrahim AN; Wang J; Deng Z; Wang M Biochem Biophys Res Commun; 2019 Aug; 516(3):999-1006. PubMed ID: 31277942 [TBL] [Abstract][Full Text] [Related]
17. The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance. Hersh DS; Harder BG; Roos A; Peng S; Heath JE; Legesse T; Kim AJ; Woodworth GF; Tran NL; Winkles JA Neuro Oncol; 2018 Sep; 20(10):1321-1330. PubMed ID: 29897522 [TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K/AKT and MEK/ERK signaling pathways. Li S; Chen X; Mao L; Zahid KR; Wen J; Zhang L; Zhang M; Duan J; Duan J; Yin X; Wang Y; Zhao L; Tang X; Wang X; Xu G Brain Res; 2018 Aug; 1692():154-162. PubMed ID: 29782850 [TBL] [Abstract][Full Text] [Related]